We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLUU
4351
PUT
DELISTED
Glu Mobile Inc.
GLUU
$2.06M ﹤0.01%
222,600
+104,300
+88% +$888K
LEGR icon
4352
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$133M
$2.06M ﹤0.01%
70,178
+17,465
+33% +$482K
OXFD
4353
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.06M ﹤0.01%
158,464
+52,129
+49% +$626K
AVEO
4354
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.06M ﹤0.01%
400,003
+383,720
+2,357% +$2.42M
ENFR icon
4355
Alerian Energy Infrastructure ETF
ENFR
$521M
$2.06M ﹤0.01%
147,667
-134,486
-48% -$1.8M
RSPM icon
4356
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$186M
$2.05M ﹤0.01%
+100,575
New +$1.92M
UWM icon
4357
CALL
ProShares Ultra Russell2000
UWM
$243M
$2.05M ﹤0.01%
84,400
-22,800
-21% -$477K
SWN
4358
DELISTED
Southwestern Energy Company
SWN
$2.05M ﹤0.01%
801,389
+465,913
+139% +$1.33M
ARGX icon
4359
PUT
argenx
ARGX
$54.2B
$2.05M ﹤0.01%
9,100
-3,200
-26% -$568K
SYNA icon
4360
PUT
Synaptics
SYNA
$4.09B
$2.05M ﹤0.01%
34,100
-9,600
-22% -$602K
LBTYK icon
4361
CALL
Liberty Global Class C
LBTYK
$3.41B
$2.05M ﹤0.01%
95,200
+24,400
+34% +$487K
PRTA icon
4362
Prothena Corp
PRTA
$468M
$2.05M ﹤0.01%
195,764
-560,667
-74% -$6.23M
LAZ icon
4363
CALL
Lazard
LAZ
$4.16B
$2.05M ﹤0.01%
71,500
+41,700
+140% +$1.13M
UBS icon
4364
UBS Group
UBS
$177B
$2.05M ﹤0.01%
177,315
+51,833
+41% +$534K
GNL icon
4365
Global Net Lease
GNL
$1.95B
$2.05M ﹤0.01%
122,280
-193,958
-61% -$2.77M
IVOO icon
4366
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.91B
$2.05M ﹤0.01%
+34,040
New +$1.92M
EPZM
4367
DELISTED
Epizyme, Inc
EPZM
$2.04M ﹤0.01%
127,337
+86,422
+211% +$1.51M
CUBE icon
4368
CubeSmart
CUBE
$9.23B
$2.04M ﹤0.01%
75,731
+65,574
+646% +$1.73M
ENTG icon
4369
CALL
Entegris
ENTG
$22B
$2.04M ﹤0.01%
34,600
-10,400
-23% -$578K
FRI icon
4370
First Trust S&P REIT Index Fund
FRI
$201M
$2.04M ﹤0.01%
97,598
+4,635
+5% +$93.7K
CRI icon
4371
PUT
Carter's
CRI
$1.48B
$2.04M ﹤0.01%
25,300
+10,100
+66% +$804K
SMTC icon
4372
CALL
Semtech
SMTC
$12.2B
$2.04M ﹤0.01%
39,100
+22,400
+134% +$1.05M
QVCGA
4373
PUT
DELISTED
QVC Group Inc Series A
QVCGA
$2.04M ﹤0.01%
4,425
+3,564
+414% +$1.39M
PETS icon
4374
PetMed Express
PETS
$42.1M
$2.04M ﹤0.01%
57,249
+6,129
+12% +$213K
MGI
4375
DELISTED
MoneyGram International, Inc. New
MGI
$2.04M ﹤0.01%
635,330
+498,342
+364% +$1.08M

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.